NCT03387384

Brief Summary

This study aims to describe the demographic characteristics and current status of the aspirin use for primary and secondary prevention of cardiovascular diseases in a large, multicenter nationwide study

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 2, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

June 30, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2019

Completed
Last Updated

December 19, 2018

Status Verified

December 1, 2018

Enrollment Period

1 year

First QC Date

December 1, 2017

Last Update Submit

December 14, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of appropriate aspirin use in the primary prevention of cardiovascular diseases

    Appropriate aspirin use will be defined with US Preventive Services Task Force (USPSTF).

    12 months

Interventions

Non-interventional study

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All consecutive patients over the age of 18 using aspirin who presented to cardiology outpatient clinics will be screened

You may qualify if:

  • Patients using aspirin 18 years and older

You may not qualify if:

  • Patients under 18 years of age
  • Patients who do not want to participate in our study
  • Patients who do not use aspirin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mugla Sitki Kocman University Training and Research Hospital

Muğla, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Celik O, Cil C, Ozlek B, Ozlek E, Dogan V, Basaran O, Demirci E, Bekar L, Kalcik M, Karaarslan O, Yetim M, Dogan T, Demir V, Kalkan S, Ozkan B, Hidayet S, Taylan G, Kucuksu Z, Celik Y, Efe SC, Aslan O, Biteker M. Design and rationale for the ASSOS study: Appropriateness of aspirin use in medical outpatients a multicenter and observational study. Anatol J Cardiol. 2018 Dec;20(6):354-362. doi: 10.14744/AnatolJCardiol.2018.47587.

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Faculty of Medicine, Department of Cardiology, M.D., Principal Investigator

Study Record Dates

First Submitted

December 1, 2017

First Posted

January 2, 2018

Study Start

June 30, 2018

Primary Completion

June 30, 2019

Study Completion

July 30, 2019

Last Updated

December 19, 2018

Record last verified: 2018-12

Locations